Medical Care

Biobanking - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
The global market for Biobanking was estimated to be worth US$ 2935 million in 2023 and is forecast to a readjusted size of US$ 4707.9 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biobanking, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biobanking by region & country, by Type, and by Application.
The Biobanking market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
Market Segmentation
By Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Segment by Type:
Equipment
Consumable
Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biobanking manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biobanking in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biobanking in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Biobanking Product Introduction
1.2 Global Biobanking Market Size Forecast
1.3 Biobanking Market Trends & Drivers
1.3.1 Biobanking Industry Trends
1.3.2 Biobanking Market Drivers & Opportunity
1.3.3 Biobanking Market Challenges
1.3.4 Biobanking Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biobanking Players Revenue Ranking (2023)
2.2 Global Biobanking Revenue by Company (2019-2024)
2.3 Key Companies Biobanking Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biobanking Product Offered
2.5 Key Companies Time to Begin Mass Production of Biobanking
2.6 Biobanking Market Competitive Analysis
2.6.1 Biobanking Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biobanking Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobanking as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Equipment
3.1.2 Consumable
3.2 Global Biobanking Sales Value by Type
3.2.1 Global Biobanking Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biobanking Sales Value, by Type (2019-2030)
3.2.3 Global Biobanking Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Virtual Biobanks
4.1.2 Tissue Biobanks
4.1.3 Population Biobanks
4.2 Global Biobanking Sales Value by Application
4.2.1 Global Biobanking Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biobanking Sales Value, by Application (2019-2030)
4.2.3 Global Biobanking Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biobanking Sales Value by Region
5.1.1 Global Biobanking Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biobanking Sales Value by Region (2019-2024)
5.1.3 Global Biobanking Sales Value by Region (2025-2030)
5.1.4 Global Biobanking Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biobanking Sales Value, 2019-2030
5.2.2 North America Biobanking Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biobanking Sales Value, 2019-2030
5.3.2 Europe Biobanking Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biobanking Sales Value, 2019-2030
5.4.2 Asia Pacific Biobanking Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biobanking Sales Value, 2019-2030
5.5.2 South America Biobanking Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biobanking Sales Value, 2019-2030
5.6.2 Middle East & Africa Biobanking Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biobanking Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biobanking Sales Value
6.3 United States
6.3.1 United States Biobanking Sales Value, 2019-2030
6.3.2 United States Biobanking Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biobanking Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biobanking Sales Value, 2019-2030
6.4.2 Europe Biobanking Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biobanking Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biobanking Sales Value, 2019-2030
6.5.2 China Biobanking Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biobanking Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biobanking Sales Value, 2019-2030
6.6.2 Japan Biobanking Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biobanking Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biobanking Sales Value, 2019-2030
6.7.2 South Korea Biobanking Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biobanking Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biobanking Sales Value, 2019-2030
6.8.2 Southeast Asia Biobanking Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biobanking Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biobanking Sales Value, 2019-2030
6.9.2 India Biobanking Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biobanking Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Profile
7.1.2 Thermo Fisher Main Business
7.1.3 Thermo Fisher Biobanking Products, Services and Solutions
7.1.4 Thermo Fisher Biobanking Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Recent Developments
7.2 Beckman Coulter
7.2.1 Beckman Coulter Profile
7.2.2 Beckman Coulter Main Business
7.2.3 Beckman Coulter Biobanking Products, Services and Solutions
7.2.4 Beckman Coulter Biobanking Revenue (US$ Million) & (2019-2024)
7.2.5 Beckman Coulter Recent Developments
7.3 Panasonic
7.3.1 Panasonic Profile
7.3.2 Panasonic Main Business
7.3.3 Panasonic Biobanking Products, Services and Solutions
7.3.4 Panasonic Biobanking Revenue (US$ Million) & (2019-2024)
7.3.5 SOL Group Recent Developments
7.4 SOL Group
7.4.1 SOL Group Profile
7.4.2 SOL Group Main Business
7.4.3 SOL Group Biobanking Products, Services and Solutions
7.4.4 SOL Group Biobanking Revenue (US$ Million) & (2019-2024)
7.4.5 SOL Group Recent Developments
7.5 Promega
7.5.1 Promega Profile
7.5.2 Promega Main Business
7.5.3 Promega Biobanking Products, Services and Solutions
7.5.4 Promega Biobanking Revenue (US$ Million) & (2019-2024)
7.5.5 Promega Recent Developments
7.6 Merck
7.6.1 Merck Profile
7.6.2 Merck Main Business
7.6.3 Merck Biobanking Products, Services and Solutions
7.6.4 Merck Biobanking Revenue (US$ Million) & (2019-2024)
7.6.5 Merck Recent Developments
7.7 Greiner Bio One
7.7.1 Greiner Bio One Profile
7.7.2 Greiner Bio One Main Business
7.7.3 Greiner Bio One Biobanking Products, Services and Solutions
7.7.4 Greiner Bio One Biobanking Revenue (US$ Million) & (2019-2024)
7.7.5 Greiner Bio One Recent Developments
7.8 Chart Industries
7.8.1 Chart Industries Profile
7.8.2 Chart Industries Main Business
7.8.3 Chart Industries Biobanking Products, Services and Solutions
7.8.4 Chart Industries Biobanking Revenue (US$ Million) & (2019-2024)
7.8.5 Chart Industries Recent Developments
7.9 Brooks Life Science
7.9.1 Brooks Life Science Profile
7.9.2 Brooks Life Science Main Business
7.9.3 Brooks Life Science Biobanking Products, Services and Solutions
7.9.4 Brooks Life Science Biobanking Revenue (US$ Million) & (2019-2024)
7.9.5 Brooks Life Science Recent Developments
7.10 Tecan Group
7.10.1 Tecan Group Profile
7.10.2 Tecan Group Main Business
7.10.3 Tecan Group Biobanking Products, Services and Solutions
7.10.4 Tecan Group Biobanking Revenue (US$ Million) & (2019-2024)
7.10.5 Tecan Group Recent Developments
7.11 QIAGEN
7.11.1 QIAGEN Profile
7.11.2 QIAGEN Main Business
7.11.3 QIAGEN Biobanking Products, Services and Solutions
7.11.4 QIAGEN Biobanking Revenue (US$ Million) & (2019-2024)
7.11.5 QIAGEN Recent Developments
7.12 BD
7.12.1 BD Profile
7.12.2 BD Main Business
7.12.3 BD Biobanking Products, Services and Solutions
7.12.4 BD Biobanking Revenue (US$ Million) & (2019-2024)
7.12.5 BD Recent Developments
7.13 Lifeline Scientific
7.13.1 Lifeline Scientific Profile
7.13.2 Lifeline Scientific Main Business
7.13.3 Lifeline Scientific Biobanking Products, Services and Solutions
7.13.4 Lifeline Scientific Biobanking Revenue (US$ Million) & (2019-2024)
7.13.5 Lifeline Scientific Recent Developments
7.14 Hamilton
7.14.1 Hamilton Profile
7.14.2 Hamilton Main Business
7.14.3 Hamilton Biobanking Products, Services and Solutions
7.14.4 Hamilton Biobanking Revenue (US$ Million) & (2019-2024)
7.14.5 Hamilton Recent Developments
7.15 So-Low
7.15.1 So-Low Profile
7.15.2 So-Low Main Business
7.15.3 So-Low Biobanking Products, Services and Solutions
7.15.4 So-Low Biobanking Revenue (US$ Million) & (2019-2024)
7.15.5 So-Low Recent Developments
7.16 TTP Labtech Ltd
7.16.1 TTP Labtech Ltd Profile
7.16.2 TTP Labtech Ltd Main Business
7.16.3 TTP Labtech Ltd Biobanking Products, Services and Solutions
7.16.4 TTP Labtech Ltd Biobanking Revenue (US$ Million) & (2019-2024)
7.16.5 TTP Labtech Ltd Recent Developments
7.17 Biolife Solutions
7.17.1 Biolife Solutions Profile
7.17.2 Biolife Solutions Main Business
7.17.3 Biolife Solutions Biobanking Products, Services and Solutions
7.17.4 Biolife Solutions Biobanking Revenue (US$ Million) & (2019-2024)
7.17.5 Biolife Solutions Recent Developments
7.18 DNA Genotek
7.18.1 DNA Genotek Profile
7.18.2 DNA Genotek Main Business
7.18.3 DNA Genotek Biobanking Products, Services and Solutions
7.18.4 DNA Genotek Biobanking Revenue (US$ Million) & (2019-2024)
7.18.5 DNA Genotek Recent Developments
7.19 Custom Biogenic Systems
7.19.1 Custom Biogenic Systems Profile
7.19.2 Custom Biogenic Systems Main Business
7.19.3 Custom Biogenic Systems Biobanking Products, Services and Solutions
7.19.4 Custom Biogenic Systems Biobanking Revenue (US$ Million) & (2019-2024)
7.19.5 Custom Biogenic Systems Recent Developments
7.20 LVL Technologies
7.20.1 LVL Technologies Profile
7.20.2 LVL Technologies Main Business
7.20.3 LVL Technologies Biobanking Products, Services and Solutions
7.20.4 LVL Technologies Biobanking Revenue (US$ Million) & (2019-2024)
7.20.5 LVL Technologies Recent Developments
7.21 BioRep
7.21.1 BioRep Profile
7.21.2 BioRep Main Business
7.21.3 BioRep Biobanking Products, Services and Solutions
7.21.4 BioRep Biobanking Revenue (US$ Million) & (2019-2024)
7.21.5 BioRep Recent Developments
8 Industry Chain Analysis
8.1 Biobanking Industrial Chain
8.2 Biobanking Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biobanking Sales Model
8.5.2 Sales Channel
8.5.3 Biobanking Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Biobanking Market Trends
Table 2. Biobanking Market Drivers & Opportunity
Table 3. Biobanking Market Challenges
Table 4. Biobanking Market Restraints
Table 5. Global Biobanking Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Biobanking Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Biobanking Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Biobanking Product Type
Table 9. Key Companies Time to Begin Mass Production of Biobanking
Table 10. Global Biobanking Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobanking as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Biobanking Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Biobanking Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Biobanking Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Biobanking Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Biobanking Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Biobanking Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Biobanking Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Biobanking Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Biobanking Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Biobanking Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Biobanking Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Biobanking Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Biobanking Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Biobanking Sales Value by Region (2019-2024) & (%)
Table 27. Global Biobanking Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Biobanking Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Biobanking Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Biobanking Sales Value, (2025-2030) & (US$ Million)
Table 31. Thermo Fisher Basic Information List
Table 32. Thermo Fisher Description and Business Overview
Table 33. Thermo Fisher Biobanking Products, Services and Solutions
Table 34. Revenue (US$ Million) in Biobanking Business of Thermo Fisher (2019-2024)
Table 35. Thermo Fisher Recent Developments
Table 36. Beckman Coulter Basic Information List
Table 37. Beckman Coulter Description and Business Overview
Table 38. Beckman Coulter Biobanking Products, Services and Solutions
Table 39. Revenue (US$ Million) in Biobanking Business of Beckman Coulter (2019-2024)
Table 40. Beckman Coulter Recent Developments
Table 41. Panasonic Basic Information List
Table 42. Panasonic Description and Business Overview
Table 43. Panasonic Biobanking Products, Services and Solutions
Table 44. Revenue (US$ Million) in Biobanking Business of Panasonic (2019-2024)
Table 45. Panasonic Recent Developments
Table 46. SOL Group Basic Information List
Table 47. SOL Group Description and Business Overview
Table 48. SOL Group Biobanking Products, Services and Solutions
Table 49. Revenue (US$ Million) in Biobanking Business of SOL Group (2019-2024)
Table 50. SOL Group Recent Developments
Table 51. Promega Basic Information List
Table 52. Promega Description and Business Overview
Table 53. Promega Biobanking Products, Services and Solutions
Table 54. Revenue (US$ Million) in Biobanking Business of Promega (2019-2024)
Table 55. Promega Recent Developments
Table 56. Merck Basic Information List
Table 57. Merck Description and Business Overview
Table 58. Merck Biobanking Products, Services and Solutions
Table 59. Revenue (US$ Million) in Biobanking Business of Merck (2019-2024)
Table 60. Merck Recent Developments
Table 61. Greiner Bio One Basic Information List
Table 62. Greiner Bio One Description and Business Overview
Table 63. Greiner Bio One Biobanking Products, Services and Solutions
Table 64. Revenue (US$ Million) in Biobanking Business of Greiner Bio One (2019-2024)
Table 65. Greiner Bio One Recent Developments
Table 66. Chart Industries Basic Information List
Table 67. Chart Industries Description and Business Overview
Table 68. Chart Industries Biobanking Products, Services and Solutions
Table 69. Revenue (US$ Million) in Biobanking Business of Chart Industries (2019-2024)
Table 70. Chart Industries Recent Developments
Table 71. Brooks Life Science Basic Information List
Table 72. Brooks Life Science Description and Business Overview
Table 73. Brooks Life Science Biobanking Products, Services and Solutions
Table 74. Revenue (US$ Million) in Biobanking Business of Brooks Life Science (2019-2024)
Table 75. Brooks Life Science Recent Developments
Table 76. Tecan Group Basic Information List
Table 77. Tecan Group Description and Business Overview
Table 78. Tecan Group Biobanking Products, Services and Solutions
Table 79. Revenue (US$ Million) in Biobanking Business of Tecan Group (2019-2024)
Table 80. Tecan Group Recent Developments
Table 81. QIAGEN Basic Information List
Table 82. QIAGEN Description and Business Overview
Table 83. QIAGEN Biobanking Products, Services and Solutions
Table 84. Revenue (US$ Million) in Biobanking Business of QIAGEN (2019-2024)
Table 85. QIAGEN Recent Developments
Table 86. BD Basic Information List
Table 87. BD Description and Business Overview
Table 88. BD Biobanking Products, Services and Solutions
Table 89. Revenue (US$ Million) in Biobanking Business of BD (2019-2024)
Table 90. BD Recent Developments
Table 91. Lifeline Scientific Basic Information List
Table 92. Lifeline Scientific Description and Business Overview
Table 93. Lifeline Scientific Biobanking Products, Services and Solutions
Table 94. Revenue (US$ Million) in Biobanking Business of Lifeline Scientific (2019-2024)
Table 95. Lifeline Scientific Recent Developments
Table 96. Hamilton Basic Information List
Table 97. Hamilton Description and Business Overview
Table 98. Hamilton Biobanking Products, Services and Solutions
Table 99. Revenue (US$ Million) in Biobanking Business of Hamilton (2019-2024)
Table 100. Hamilton Recent Developments
Table 101. So-Low Basic Information List
Table 102. So-Low Description and Business Overview
Table 103. So-Low Biobanking Products, Services and Solutions
Table 104. Revenue (US$ Million) in Biobanking Business of So-Low (2019-2024)
Table 105. So-Low Recent Developments
Table 106. TTP Labtech Ltd Basic Information List
Table 107. TTP Labtech Ltd Description and Business Overview
Table 108. TTP Labtech Ltd Biobanking Products, Services and Solutions
Table 109. Revenue (US$ Million) in Biobanking Business of TTP Labtech Ltd (2019-2024)
Table 110. TTP Labtech Ltd Recent Developments
Table 111. Biolife Solutions Basic Information List
Table 112. Biolife Solutions Description and Business Overview
Table 113. Biolife Solutions Biobanking Products, Services and Solutions
Table 114. Revenue (US$ Million) in Biobanking Business of Biolife Solutions (2019-2024)
Table 115. Biolife Solutions Recent Developments
Table 116. DNA Genotek Basic Information List
Table 117. DNA Genotek Description and Business Overview
Table 118. DNA Genotek Biobanking Products, Services and Solutions
Table 119. Revenue (US$ Million) in Biobanking Business of DNA Genotek (2019-2024)
Table 120. DNA Genotek Recent Developments
Table 121. Custom Biogenic Systems Basic Information List
Table 122. Custom Biogenic Systems Description and Business Overview
Table 123. Custom Biogenic Systems Biobanking Products, Services and Solutions
Table 124. Revenue (US$ Million) in Biobanking Business of Custom Biogenic Systems (2019-2024)
Table 125. Custom Biogenic Systems Recent Developments
Table 126. LVL Technologies Basic Information List
Table 127. LVL Technologies Description and Business Overview
Table 128. LVL Technologies Biobanking Products, Services and Solutions
Table 129. Revenue (US$ Million) in Biobanking Business of LVL Technologies (2019-2024)
Table 130. LVL Technologies Recent Developments
Table 131. BioRep Basic Information List
Table 132. BioRep Description and Business Overview
Table 133. BioRep Biobanking Products, Services and Solutions
Table 134. Revenue (US$ Million) in Biobanking Business of BioRep (2019-2024)
Table 135. BioRep Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Biobanking Downstream Customers
Table 139. Biobanking Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biobanking Product Picture
Figure 2. Global Biobanking Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Biobanking Sales Value (2019-2030) & (US$ Million)
Figure 4. Biobanking Report Years Considered
Figure 5. Global Biobanking Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biobanking Revenue in 2023
Figure 7. Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Equipment Picture
Figure 9. Consumable Picture
Figure 10. Global Biobanking Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Biobanking Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Virtual Biobanks
Figure 13. Product Picture of Tissue Biobanks
Figure 14. Product Picture of Population Biobanks
Figure 15. Global Biobanking Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Biobanking Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Biobanking Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Biobanking Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Biobanking Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Biobanking Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Biobanking Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Biobanking Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Biobanking Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Biobanking Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Biobanking Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Biobanking Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Biobanking Sales Value (%), (2019-2030)
Figure 28. United States Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 34. China Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 36. China Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 46. India Biobanking Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Biobanking Sales Value by Type (%), 2023 VS 2030
Figure 48. India Biobanking Sales Value by Application (%), 2023 VS 2030
Figure 49. Biobanking Industrial Chain
Figure 50. Biobanking Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies